Transcription of Pneumococcal vaccination recommendations for …
{{id}} {{{paragraph}}}
Example: marketing
Pneumococcal vaccination recommendations for …
Underlying medical condition or other risk factorChronic heart disease2 Chronic lung disease3 Diabetes mellitusCerebrospinal fluid leakCochlear implantAlcoholismChronic liver disease, cirrhosisCigarette smoking ( 19 yrs)Sickle cell disease/other hemoglobinopathyCongenital or acquired aspleniaCongenital or acquired immunodeficiency4 HIVC hronic renal failureNephrotic syndromeLeukemiaLymphomaHodgkin diseaseGeneralized malignancyIatrogenic immunosuppression5 Solid organ transplantMultiple myelomaImmuno- competentAdminister PCV13 doses needed to complete series to children through age 71 monthsXXXXX XXXXXXXXXXXXXR outine recommendations for Pneumococcal Conjugate Vaccine (PCV13) and Pneumococcal Polysaccharide Vaccine (PPSV23)Risk GroupAdminister PCV13 series to all children beginning at age 2 months, followed by doses at 4 months, 6 months, and 12 15 months (booster dose).
Title: Pneumococcal vaccination recommendations for children and adults by age and/or risk factor Keywords: P2019, pneumococcal vaccination, pneumococcal vaccine, PCV13, PPSV23, pneumo table
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: